biosimilars

DiCE CEO Speaks at Event Marking 15 Years of First Biosimilar Approval in Europe
DiCE CEO Speaks at Event Marking 15 Years of First Biosimilar Approval in Europe

Zorana Maravic presented the view of the digestive cancer patient community at the February event “15 Years of Biosimilars: Improving Equitab...

Read

Biosimilars Education Microsite Updates
Biosimilars Education Microsite Updates

Discover our new website section dedicated to Biosimilars Education – medication that can increase accessibility for patients

...

Read

15-year Anniversary of Biosimilars in Europe – What Does This mean for Patients?
15-year Anniversary of Biosimilars in Europe – What Does This mean for Patients?

DiCE publishes biosimilars education materials for patients and health care professionals for Global Biosimilars Week

...

Read

A Call for Action on Biosimilars for Increased Accessibilty for Patients
A Call for Action on Biosimilars for Increased Accessibilty for Patients

DiCE invites those interested to endorse its Call to Action on Biosimilars to increase access for patients

...

Read

On Biosimilars - Developments in the Path to Affordable and Accessible Healthcare
On Biosimilars – Developments in the Path to Affordable and Accessible Healthcare

Digestive Cancers Europe On Biosimilars – Developments in the Path to Affordable and Accessible Healthcare

...

Read

Digestive Cancers Europe Brings Biosimilars Experts Together for Educational Project

Our workshop was the first step in deciding educational priorities for patients

...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.